Pharminent

EMA panel recommends nod for Sanofi, Regeneron’s arthritis drug

(Reuters) – A European Medicines Agency panel said on Friday it recommended granting marketing approval to Sanofi and Regeneron’s experimental drug to treat rheumatoid arthritis.

http://www.reuters.com/article/us-sanofi-fr-regeneron-pharms-ema-idUSKBN17N2BV

Filed under: Arthritis